Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues
about
Intercellular Adhesion Molecule-1 (ICAM-1) Polymorphisms and Cancer Risk: A Meta-AnalysisICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammationVascular Recruitment of Human Retinoblastoma Cells by Multi-Cellular Adhesive Interactions with Circulating Leukocytes.Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.ICAM-1 as a molecular target for triple negative breast cancerCombined effects of icam-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development.Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis.Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1PKN3 is the major regulator of angiogenesis and tumor metastasis in miceIntercellular adhesion molecule 1 is a sensitive and diagnostically useful immunohistochemical marker of papillary thyroid cancer (PTC) and of PTC-like nuclear alterations in Hashimoto's thyroiditis.Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium.Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.Inducible RasGEF1B circular RNA is a positive regulator of ICAM-1 in the TLR4/LPS pathway.CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule.Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1α/ICAM-1 signaling pathway.ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes
P2860
Q26797276-D0F02898-AF14-441D-A0D5-20E625CBB873Q27330207-5D050674-88E7-4D99-B7A1-C00E684AE5BAQ30462815-5F49D6F3-F443-4CC1-AB0F-09FD535899FFQ34015100-AF2FA4EF-D92F-44DF-9F07-8A7B759176E2Q34028841-028DD2A7-41E9-4208-A16F-F223BCCFB65BQ34383956-81E1895F-462A-4AB0-912F-E3C8E13D5789Q34998544-3543C47C-C9AE-4745-A5B6-A54E627CC6FDQ35681529-EA901D63-55ED-4587-8DD4-B3361340E9B1Q35847885-EB78E345-E3F5-40D0-9A74-DDAF0FD02BAFQ36369111-17D8D07F-6876-4979-B5CA-33CBD3E0D7DBQ36442867-F3205323-549D-4141-B660-E276DEBA7547Q36640497-0B738A9D-A4BB-4AB3-956D-410C26990AB0Q36967705-CF8B60F6-EE0C-46F4-A33A-D8370F875176Q37558112-72B1CB30-7FD1-46F3-9287-E5CF0D79BF1CQ37621036-D765D96E-BE58-4563-A792-0588B74192FDQ38166539-023AFD0B-56BB-4621-A3E0-D0ECD43853F0Q40630405-B41432CF-7AD2-43CD-99E8-096683C70BD3Q47449809-9C715E18-C542-4D32-891E-BB2D6ACB291CQ52808412-5E7D5E3D-14F6-4E0B-8910-50BEDE05D467Q54940276-4D262F5A-3D37-437E-81C3-AE6FD0EF55D5Q58799662-C2F68FB7-A20B-499A-BB43-248AD55E86E7
P2860
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues
@en
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues.
@nl
type
label
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues
@en
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues.
@nl
prefLabel
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues
@en
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues.
@nl
P2860
P1476
Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues
@en
P2093
Gail M Seigel
Sarah H Hayes
P2860
P304
P577
2009-06-10T00:00:00Z